Shots:

• ITROM to get exclusive commercialization rights for Mithra’s Myring in MENA territories (Saudi Arabia- UAE- Bahrain- Kuwait- Qatar- Oman- Lebanon- and Jordan) with a total deal value of $6.79M. Mithra strengthen its portfolio and manufacture it at CDMO facility in Belgium
• The focus of the agreement is to develop and commercialize techniques for women in fields of fertility- contraception- Hormonal Therapy (HT) & personal care and generate $15.8M in combination with their deal- in Dec 2018 to commercialize Mithra's Tibelia and Daphne Continu
• Myring (etonogestrel- 11.7mg /ethinyl estradiol-2.7mg) is a generic of NuvaRing a contraceptive vaginal ring- made of ethylene vinyl acetate copolymers for the prevention of pregnancy

Ref: Mithra | Image: Mithra